» Articles » PMID: 23483715

Contribution of Vitamin D Insufficiency to the Pathogenesis of Multiple Sclerosis

Overview
Specialty Neurology
Date 2013 Mar 14
PMID 23483715
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis (MS) is reviewed. Among the multiple recently discovered actions of vitamin D, an immunomodulatory role has been documented in experimental autoimmune encephalomyelitis and in humans. This action in the peripheral immune system is currently the main known mechanism through which vitamin D might influence MS, but other types of actions could be involved within the central nervous system. Furthermore, vitamin D insufficiency is widespread in temperate countries and in patients with MS at the earliest stages of the disease, suggesting that the deleterious effects related to vitamin D insufficiency may be exerted in these patients. In fact, many genetic and environmental risk factors appear to interact and contribute to MS. In genetics, several human leukocyte antigen (HLA) alleles (more particularly HLA-DRB1*1501) could favour the disease whereas some others could be protective. Some of the genes involved in vitamin D metabolism (e.g. CYP27B1) also play a significant role. Furthermore, three environmental risk factors have been identified: past Epstein-Barr virus infection, vitamin D insufficiency and cigarette smoking. Interactions between genetic and environmental risk or protective factors may occur during the mother's pregnancy and could continue during childhood and adolescence and until the disease is triggered in adulthood, therefore possibly modulating the MS risk throughout the first decades of life. Furthermore, some clinical findings already strongly suggest that vitamin D status influences the relapse rate and radiological lesions in patients with MS, although the results of adequately powered randomized clinical trials using vitamin D supplementation have not yet been reported. While awaiting these incontrovertible results, which might be long in coming, patients with MS who are currently in vitamin D insufficiency should be supplemented, at least for their general health status, using moderate doses of the vitamin.

Citing Articles

Vitamin D status and latitude predict brain lesions in adrenoleukodystrophy.

Van Haren K, Wilkes J, Moser A, Raymond G, Richardson T, Aubourg P Ann Child Neurol Soc. 2024; 1(2):155-161.

PMID: 38966781 PMC: 11221407. DOI: 10.1002/cns3.4.


An ultra-sensitive and high-throughput trapping-micro-LC-MS method for quantification of circulating vitamin D metabolites and application in multiple sclerosis patients.

Qu F, Zhang M, Weinstock-Guttman B, Zivadinov R, Qu J, Zhu X Sci Rep. 2024; 14(1):5545.

PMID: 38448553 PMC: 10918069. DOI: 10.1038/s41598-024-55939-0.


Vitamin D-An Effective Antioxidant in an Animal Model of Progressive Multiple Sclerosis.

Haindl M, Ucal M, Wonisch W, Lang M, Nowakowska M, Adzemovic M Nutrients. 2023; 15(15).

PMID: 37571246 PMC: 10421326. DOI: 10.3390/nu15153309.


Navigating the journey of multiple sclerosis management in Africa, overcoming hurdles and harnessing opportunities: a review.

Aderinto N, Muili A, Opanike J Ann Med Surg (Lond). 2023; 85(5):1774-1779.

PMID: 37228987 PMC: 10205356. DOI: 10.1097/MS9.0000000000000560.


A Phase 1 Study of Oral Vitamin D in Boys and Young Men With X-Linked Adrenoleukodystrophy.

Van Haren K, Cunanan K, Awani A, Gu M, Pena D, Chromik L Neurol Genet. 2023; 9(2):e200061.

PMID: 37090939 PMC: 10117697. DOI: 10.1212/NXG.0000000000200061.


References
1.
Lips P . Vitamin D physiology. Prog Biophys Mol Biol. 2006; 92(1):4-8. DOI: 10.1016/j.pbiomolbio.2006.02.016. View

2.
Grant W, Holick M . Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005; 10(2):94-111. View

3.
Handel A, Giovannoni G, Ebers G, Ramagopalan S . Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol. 2010; 6(3):156-66. DOI: 10.1038/nrneurol.2010.1. View

4.
Banwell B, Bar-Or A, Arnold D, Sadovnick D, Narayanan S, McGowan M . Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol. 2011; 10(5):436-45. DOI: 10.1016/S1474-4422(11)70045-X. View

5.
van der Mei I, Ponsonby A, Engelsen O, Pasco J, McGrath J, Eyles D . The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect. 2007; 115(8):1132-9. PMC: 1940076. DOI: 10.1289/ehp.9937. View